Last reviewed · How we verify
NCT03701152
Comparison Between Two Different Protocols of Negative Pressure Therapy for Healing of Chronic Ulcers
NA trial testing Negative pressure therapy in Chronic Ulcers in 30 participants. Status unknown.
1 October 2018
Quick facts
| Lead sponsor | Badr University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 January 2018 |
| Primary completion | 1 October 2018 |
| Estimated completion | 1 December 2018 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Negative pressure therapy
Conditions studied
- Chronic Ulcers — all drugs for Chronic Ulcers →
- Negative Pressure Therapy — all drugs for Negative Pressure Therapy →
Sponsor
Badr University
Who can join
Adults 27 to 65, any sex, with Chronic Ulcers or Negative Pressure Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Negative Pressure Wound Therapy (NPWT), is a non invasive wound management tool which develops from negative pressure being applied to the wound. This promotes healing through the removal of infectious materials and enhancing granulation tissue formation. NPWT eases debridement as well as promoting healing of different types of wounds.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison between two different protocols of negative pressure therapy for healing of chronic ulcers.
Mohammed AH, Hamed SA, Abdelghany AI. · · 2020 · cited 3× · PMID 31677995 · DOI 10.1016/j.jtv.2019.10.003
Verify or expand the search:
- PubMed search for NCT03701152
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Negative pressure therapy
Trials testing the same drug.
- NCT05247086 — Negative Pressure Therapy After Infected Mesh Removal. · NA · unknown
- NCT05474911 — PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY. · NA · unknown
- NCT05761353 — Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema · NA · completed
- NCT03816787 — Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain · NA · unknown
Other Badr University trials
Trials by the same sponsor.
- NCT07395895 — Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women · Phase 3 · not yet recruiting
- NCT07399743 — Effects of Lower Body Positive Pressure Therapy Versus Alpha Lipoic Acid and Omega-3 Fatty Acids on Knee Osteoarthritis · Phase 3 · not yet recruiting
- NCT07272967 — Metformin in Preventing Secondary Gliosis Following Acute Thoraco-Lumbar Spinal Cord Injury · Phase 4 · not yet recruiting
- NCT07296146 — Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients. · Phase 3 · not yet recruiting
- NCT07180745 — Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03701152 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Badr University
- Last refreshed: 9 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03701152.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing